Table 2.
Characteristics of survey respondents
| Characteristics | All respondents (n = 83) | Respondents from biopharmaceutical companies (n = 43) | Respondents from clinical research organizations (n = 40) |
|---|---|---|---|
| Type of companya (frequency counts %) | |||
| Large biopharmaceutical company | 41 (50) | 41 (95) | – |
| Small/medium-sized biopharmaceutical company | 2 (2) | 2 (5) | – |
| Large CRO | 16 (19) | – | 16 (40) |
| Small/medium-sized CRO | 24 (29) | – | 24 (60) |
| Position (frequency counts %) | |||
| Clinical operations responsible | 48 (58) | 35 (81) | 13 (33) |
| Study manager | 13 (16) | 5 (12) | 8 (20) |
| Monitor | 22 (26) | 3 (7) | 19 (47) |
| Experience (frequency counts %) | |||
| < 2 years | 5 (6) | 1 (2) | 4 (10) |
| 2–5 years | 11 (13) | 4 (9) | 7 (17) |
| > 5 years | 67 (81) | 38 (89) | 29 (73) |
a Company size was defined in accordance with the definition by the European Commission: Small/medium-sized = employees < 250 and turnover < 50 million € globally (http://ec.europa.eu/growth/smes/business-friendly-environment/sme-definition_da)